
New Antibiotic Combination Shows Promise Against Drug-Resistant Bacterial Infections
An Indian journal-watch report dated 26 October summarised a Phase 2 multicentre study of cefepime-zidebactam for infections caused by carbapenem-resistant Gram-negative bacteria. Among 60 clinically and microbiologically evaluable participants, the reported investigator-assessed clinical cure rate was 91.7%.













